{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:22:37Z","timestamp":1784924557573,"version":"3.55.0"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5S","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.juro.2008.03.012","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T09:20:35Z","timestamp":1207732835000},"source":"Crossref","is-referenced-by-count":1,"title":["Commentary on Tolterodine for Men With Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms"],"prefix":"10.1097","volume":"179","author":[{"given":"Michael P.","family":"O\u2019Leary","sequence":"first","affiliation":[{"name":"Department of Surgery, Division of Urology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2008.03.012_bib1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1464-410X.2004.05022.x","article-title":"Pharmacological therapy of benign prostatic hyperplasia\/lower urinary tract symptoms: an overview for the practicing clinician","volume":"94","author":"Chapple","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2008.03.012_bib2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2008.03.012_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.03.012_bib4","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708005545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534708005545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2008.03.012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:00:04Z","timestamp":1784923204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1016\/j.juro.2008.03.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":4,"journal-issue":{"issue":"5S","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1016\/j.juro.2008.03.012"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2008.03.012","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}